Press Release – New York, NY – July 30, 2026 – Sichenzia Ross Ference Carmel LLP announced today that it represented Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients’ lives, in its recently announced private placement of up to $30.1 million.
The SRFC team was led by partners Gregory Sichenzia, Avital Perlman and Marcelle Balcombe, with associate Rohini Sud.